Joseph Talamo
CIK 1524547 · Chief Financial Officer · last filed 2026-01-05
Joseph Talamo is a Chief Financial Officer who has filed 30 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing shows the insider was granted $3.8K of INTS on Jan 5, 2026. Current disclosed insider exposure totals $103.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$103.8K
4
30
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INTS | Chief Financial Officer | 28,661 | $3.62 | $103.8K | $0 | 5 | 2026-01-05 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | SVP and CFO | 59,644 | $6.40 | $381.5K | $0 | 17 | 2020-01-15 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Chief Accounting Officer | 30,839 | — | — | $0 | 6 | 2015-06-04 |
| LISATA THERAPEUTICS, INC. (NBS.WS) Delisted | See Remarks | — | — | — | $0 | 2 | 2012-01-06 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | INTS | Grant (A) | +14,482 | $3.8K | EDGAR |
| 2025-07-02 | INTS | Grant (A) | +14,179 | $3.7K | EDGAR |
| 2025-05-06 | INTS | Grant (A) | — | $0 | EDGAR |
| 2024-10-23 | INTS | Grant (A) | — | $0 | EDGAR |
| 2023-12-12 | INTS | Grant (A) | — | $0 | EDGAR |
| 2020-01-15 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +14,209 | -$15.9K | EDGAR |
| 2020-01-09 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Tax (F) | −1,821 | -$5.2K | EDGAR |
| 2019-01-16 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +13,841 | $0 | EDGAR |
| 2019-01-10 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Tax (F) | −1,795 | -$8.3K | EDGAR |
| 2018-06-21 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +6,893 | $59.6K | EDGAR |